Ventricular Assist Device Market to Rise at 11.9% CAGR over 2025-2032; Long Waiting Periods for Heart Transplants to Aid Growth

The global ventricular assist device market size was valued at USD 1.36 billion in 2024. The market is projected to grow from USD 1.49 billion in 2025 to USD 3.27 billion by 2032, exhibiting a CAGR of 11.9% during the forecast period.

Fortune Business Insights™ presents this information in its latest report titled “ Ventricular Assist Device Market Size, Share & Industry Analysis, By Product (Left Ventricular Assist Device, Right Ventricular Assist Device, and Bi-Ventricular Assist Device), By Type of Flow (Pulsatile Flow and Continuous Flow), By Application (Bridge to Transplant (BTT), Bridge to Candidacy (BTC), Destination Therapy (DT), and Bridge to Recovery (BTR)), By End-user (Hospitals & ASCs and Specialty Clinics & Others), and Regional Forecast, 2025-2032”.

Heart Failure (HF) prevalence has been rising significantly on a global scale. The prevalence of the condition is rising as a result of various factors, including bad food and lifestyle changes. According to a piece written by the AME Publishing Company, 64.4 million people worldwide were expected to have heart failure in 2020. 51.0% of the individuals who had heart failure overall had severe heart failure. A mechanical circulatory support system called a Ventricular Assist Device (VAD) is implanted in heart failure patients with severe symptoms and works by circulating blood from the heart's chambers to the entire body.

COVID-19 Pandemic Caused Various Roadblocks for the Market

During the pandemic, COVID-19's effects caused a reduction in the growth of the global market for ventricular assist devices. A decline in the number of VAD transplantations was carried out as a result of numerous non-emergency surgeries being postponed due to the COVID-19 pandemic. Further affecting the market's growth was the interruption of the supply chains.  

CARMAT Bagged Regulatory Approval in New EFS Study 

In the Early Feasibility Study, CARMAT has been given permission to employ a new version of their artificial heart. Based on the clinical knowledge gathered from the PIVOTAL trial, the prosthesis and wearable systems have been improved in this new edition.

Technological Advances to Transform Market Outlook   

Artificial intelligence is helping healthcare professionals capture and monitor clinical data routinely with the least amount of error possible due to technological breakthroughs in the sector. The healthcare sector benefits greatly from the high-performance capabilities of Artificial Intelligence (AI) algorithms. These factors augment the Ventricular Assist Device Market growth.

Competitive Landscape

Major Players Dominate Market owing to Robust VAD Sales

Abbott and ABIOMED are two well-known market players who dominated the Ventricular Assist Device Market share in 2022. A sizeable portion of the global market for ventricular assist devices was held by Abbott. The company's successful device sales are to blame for this. Additionally, the business places a high priority on strategic projects that will enable it to diversify its product offerings globally.

Notable Industry Development:

• July 2020: Berlin Heart finished the post-approval surveillance for EXCOR Pediatric VAD to support patients.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/ventricular-assist-device-market-106377

List of the Companies Profiled:

• Berlin Heart (Germany)
• ABIOMED (U.S.)
• Abbott (U.S.)
• Jarvik Heart, Inc. (U.S.)

Further Report Findings

• In 2024, the North American market had a value of USD 0.69 billion. The rising incidence of cardiovascular disorders in the area is attributed to the domination of this regional market. Moreover, the adoption of these devices in the region has been fueled by an increase in collaborations and agreements among the major players that emphasize the growth of this market.
• Due to increased market investments and the introduction of newer products, Europe, which had the second-largest market share, is predicted to witness rapid growth.

Table of Segmentation